These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21351310)

  • 1. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study.
    van Hunsel F; Talsma A; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):286-91. PubMed ID: 21351310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
    van Hunsel F; de Waal S; Härmark L
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential competition bias in the detection of safety signals from spontaneous reporting databases.
    Pariente A; Didailler M; Avillach P; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Moore N
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1166-71. PubMed ID: 20848561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.
    Schuemie MJ
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):292-9. PubMed ID: 20945505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.
    Conforti A; Opri S; D'Incau P; Sottosanti L; Moretti U; Ferrazin F; Leone R
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):597-602. PubMed ID: 22337264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct reporting of side effects by the patient: favourable experience in the first year].
    van Grootheest AC; Passier JL; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal detection in pharmacovigilance: empirical evaluation of data mining tools.
    Chan KA; Hauben M
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):597-9. PubMed ID: 16134080
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do pharmacists' reports of adverse drug reactions reflect patients' concerns?
    van Grootheest K; van Puijenbroek EP; de Jong-van den Berg LT
    Pharm World Sci; 2004 Jun; 26(3):155-9. PubMed ID: 15230363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
    Labadie J; van Grootheest AC
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reported adverse drug reactions and their determinants in Dutch children outside the hospital.
    Schirm E; Tobi H; van Puijenbroek EP; Monster-Simons MH; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):159-65. PubMed ID: 15072115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologies for the detection of adverse drug reactions: comparison of hospital databases, chart review and spontaneous reporting.
    Miguel A; Azevedo LF; Lopes F; Freitas A; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):98-102. PubMed ID: 23027707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.